Effect of Whole Body Electromyostimulation and/or Protein Supplementation

Status Completed

Clinical Trial Summary

The aim of the study is to determine the effect of 16 weeks of Whole Body-Electromyostimulation (WB-EMS) and/or protein supplementation on Sarcopenic Obesity (SO) in community dwelling male subjects 70+ with SO .

108 eligible men will be randomly assigned to either a (1) WB-EMS and Protein (2) Protein (3) sedentary control group.

WB-EMS will be applied 1,5 x 20 min per week (i.e. 3 sessions in two weeks) with bipolar current, 85 Hz in an intermitted mode (4 s - 4 s of rest). Protein supplementation will be adjusted to dietary intake in order to reach a total protein intake between 1,5 - 1,7g/kg body-mass/d . Primary study endpoint will be the Sarcopenia Z-Score

Clinical Trial Description

The aim of the study is to evaluate the effects of Whole-Body Electromyostimulation (WB-EMS) with additional protein supplementation on Sarcopenic Obesity parameters in independently living men 70 years and older with sarcopenic obesity. The randomized controlled study compares three groups with 36 subjects each: (1) WB-EMS with additional protein supplementation, (2) protein-only and (3) passive control group, over a period of 16 weeks of WB-EMS -training. Group (1) conducts 1.5-times/week a 20 minute-sessions of WB-EMS with additional protein, group (2) is limited to protein supplementation (only) and group (3) is constrained to maintain their habitual living behavior and physical activity. Based on an individual nutrition analysis the protein intake will be adjusted to 1.5-1.7 g/kg/ bodymass/d. All groups will be supplemented with a maximum of 800 IE Vitamin D.

Primary study endpoint will be changes of the Sarcopenia Z-Score with skeletal muscle mass assessed via bio-impedance analysis (BIA). Secondary study endpoints are changes of Obesity (i.e. body-fat as assessed via BIA), cardiometabolic risk (i.e. Metabolic Syndrome Z-Score), strength parameters evaluated via Dr. Wolff BackCheck and Physiomed LegPress, quality of life (SF-12) and functional disability (late life physical disability index). ;

Study Design

Related Conditions & MeSH terms

Clinical Trial Details

NCT number	NCT02857660
Study type	Interventional
Source	University of Erlangen-Nürnberg Medical School
Contact
Status	Completed
Phase	Phase 3
Start date	August 2016
Completion date	April 2017

View Details

See also
Status	Clinical Trial	Phase
Completed	`NCT03119610` - The Physiologic Effects of Intranasal Oxytocin on Sarcopenic Obesity	Phase 1/Phase 2
Recruiting	`NCT03212391` - WAVE Study- Walking and Aging in VErona Study	N/A
Recruiting	`NCT05289219` - Effects of Physical Exercise on Sarcopenia After Bariatric Surgery	N/A
Completed	`NCT05143398` - Nutritional Supplementation in Sarcopenic Obesity	N/A
Completed	`NCT04122638` - Prevalence of Sarcopenia and Sarcopenic Obesity in Older Adults
Recruiting	`NCT05582668` - Sarcopenia After Bariatric Surgery in Older Patients: A Cohort Study
Active, not recruiting	`NCT02379026` - Lifestyle Modifications for the Treatment of Sarcopenic Obesity	N/A
Enrolling by invitation	`NCT05638035` - Effects of Obesity on Rectus Femoris Muscle Thickness, Sarcopenia, Gait and Balance in Women
Recruiting	`NCT05477277` - Adverse Outcomes and Mortality in Liver Transplant	N/A
Not yet recruiting	`NCT04597788` - Efficacy of Protein Supplemented Very Low Calorie Meals on Weight Loss	N/A
Completed	`NCT04771377` - Effect of Protein Supplementation and a Structured Exercise Program on Muscle in Women After Bariatric Surgery.	N/A
Recruiting	`NCT03347773` - Oral Nutritional Supplement Intervention Among Hemodialysis Patients With Sarcopenic Obesity	N/A
Active, not recruiting	`NCT04272073` - A High-PRotein Mediterranean Diet and Resistance Exercise for Cardiac Rehabilitation	N/A
Recruiting	`NCT06320158` - Dissecting the Molecular and Cellular Pathophysiology of Sarcopenic Obesity in the Elderly
Completed	`NCT03863379` - Sarcopenic Obesity in Neurodisabilities
Recruiting	`NCT04221750` - Diet and Exercise Plus Metformin to Treat Frailty in Obese Seniors	Phase 3
Completed	`NCT05918159` - Effects of Sarcopenia on General Health Status in Elderly: a Population-based Study
Completed	`NCT05029713` - Sarcopenic Obesity in Liver Transplanted Patients
Completed	`NCT03370211` - Resistance Training and Sarcopenic Obesity Elderly Women	N/A
Recruiting	`NCT05734755` - Dietary Programme and Exercise Training in Combination or Separately on Managing Sarcopenic Obesity in Older Adults	N/A

Clinical trials are conducted in a series of steps, called phases - each phase is designed to answer a separate research question.

Phase 1: Researchers test a new drug or treatment in a small group of people for the first time to evaluate its safety, determine a safe dosage range, and identify side effects.
Phase 2: The drug or treatment is given to a larger group of people to see if it is effective and to further evaluate its safety.
Phase 3: The drug or treatment is given to large groups of people to confirm its effectiveness, monitor side effects, compare it to commonly used treatments, and collect information that will allow the drug or treatment to be used safely.
Phase 4: Studies are done after the drug or treatment has been marketed to gather information on the drug's effect in various populations and any side effects associated with long-term use.

Effect of Whole Body Electromyostimulation and/or Protein Supplementation on Sarcopenic Obesity in 70+ — FRANSO

Clinical Trial Summary

Clinical Trial Description

Study Design

Related Conditions & MeSH terms